@article{Andanalusia_Akbar_Pradiningsih_2022, title={IAI SPECIAL EDITION: Drug therapy for COVID-19 inpatients in West Nusa Tenggara hospital}, volume={22}, url={https://pharmacyeducation.fip.org/pharmacyeducation/article/view/1617}, DOI={10.46542/pe.2022.222.180183}, abstractNote={<p><strong>Background</strong>: COVID-19 represents an unprecedented challenge to the world. Various attempts have been made to overcome COVID-19, including employing multiple drug therapies.       </p> <p><strong>Objective</strong>: This study was conducted to describe the drug therapy of COVID-19 inpatients at the West Nusa Tenggara Hospital in 2020.      </p> <p><strong>Methods</strong>: Observation of 102 patients was conducted retrospectively. Data collection was performed by analysing medical records.       </p> <p><strong>Results</strong>: A total of 62 out of the 102 patients (60.8%) were hospitalised more than four weeks. 57 patients (55.9%) received antivirus therapy with Oseltamivir and 47 patients (46.1%) recieved azithromycin as adjuvant antibiotic therapy. Most of the patients (63.7%) received vitamin C as an immunomodulator. A small number of patients received other supportive therapies recommended to decrease the symptoms of COVID-19. The most frequent administered therapies for COVID-19 patients hospitalised at the West Nusa Tenggara Hospital are antivirals, antibiotics, and immunomodulatory.       </p> <p><strong>Conclusion</strong>:  The findings provide an overview of therapy use for COVID-19 inpatients in West Nusa Tenggara Hospital. There is a need to assess the effectiveness of the therapy to promote safe and effective use of drugs for COVID-19 patients in the future.</p>}, number={2}, journal={Pharmacy Education}, author={Andanalusia, Mahacita and Akbar, Shah Iqbal Ikraman and Pradiningsih, Anna}, year={2022}, month={Mar.}, pages={p. 180–183} }